DocGo (NASDAQ:DCGO - Get Free Report) will likely be releasing its Q1 2025 earnings data after the market closes on Thursday, May 8th. Analysts expect DocGo to post earnings of ($0.01) per share and revenue of $104.25 million for the quarter.
DocGo Stock Performance
NASDAQ:DCGO traded up $0.11 during trading hours on Friday, reaching $2.31. The company's stock had a trading volume of 659,350 shares, compared to its average volume of 742,406. The firm has a 50-day simple moving average of $2.64 and a 200-day simple moving average of $3.73. DocGo has a 1 year low of $2.02 and a 1 year high of $5.68. The firm has a market capitalization of $235.58 million, a price-to-earnings ratio of 8.25, a PEG ratio of 14.16 and a beta of 1.12.
Wall Street Analysts Forecast Growth
Several brokerages recently weighed in on DCGO. Deutsche Bank Aktiengesellschaft cut DocGo from a "buy" rating to a "hold" rating and dropped their target price for the company from $5.00 to $2.85 in a report on Friday, February 28th. Needham & Company LLC reiterated a "buy" rating and issued a $4.00 price objective on shares of DocGo in a research report on Tuesday, April 8th. Finally, Stifel Nicolaus cut their price objective on DocGo from $6.50 to $5.50 and set a "buy" rating on the stock in a research report on Friday, February 28th. One analyst has rated the stock with a hold rating and five have issued a buy rating to the stock. According to data from MarketBeat.com, DocGo currently has an average rating of "Moderate Buy" and an average target price of $4.89.
View Our Latest Research Report on DocGo
DocGo Company Profile
(
Get Free Report)
DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.
Further Reading
Before you consider DocGo, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DocGo wasn't on the list.
While DocGo currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
